Non-invasive diagnostic method for the evaluation of intestinal lactase deficiency (hypolactasia)

Abstract

The test of the invention comprises the measuring the total amount of xylose in urine and / or its concentration in blood following oral administration of 4-O-β-D-galactopyranosyl-D-xylose (4-GX) to the patient. It is a non-invasive test that is based on the direct evaluation of the global enzyme activity in the whole individual, not on measuring the metabolic consequences derived from its deficiency. It does not require specialised equipment, does not cause apparent discomfort in patients with lactase deficiency and is very reliable, thus overcoming the drawbacks of the diagnostic tests currently in use and is a statistically significantly better test in terms of its reliability; consequently it should become the reference or gold standard test for the indication of hypolactasia.

Description

CROSS REFERENCE TO RELATED APPLICATIONS[0001]This application claims priority under 35 U.S.C. §119(e) of U.S. Provisional Patent Application No. 61 / 433,002 for “Non-Invasive Diagnostic Method for the Evaluation of Intestinal Lactase Deficiency (Hypolactasia)” filed on Jan. 14, 2011 in the name of Juan José ARAGÓN REYES et al., which is hereby incorporated herein in its entirety.TECHNICAL FIELD OF THE INVENTION[0002]The invention is included in the pharmaceutical sector and is applicable in the medical diagnostic sector for the evaluation of intestinal lactase activity, specifically in intestinal lactase deficiency (hypolactasia) in humans as a non-invasive test of the activity of this enzyme.STATE OF THE ART[0003]Intestinal lactase is the enzyme responsible for lactose digestion. Lactase is located in the microvilli, which constitute the so-called brush border of the enterocytes of the small intestine, it is an integral protein of the cell membrane with its active centre directed to...

AI Technical Summary

Benefits of technology

[0031]By means of the statistical data shown in the present invention regarding the optimum doses and times used for the tests described in the present invention compared to data obtained by the other tests performed and that are part of the state of the art, it is concluded that the test of measuring intestinal lactase activity by the administration of 4-GX, described in the present invention, be considered to be the reference or gold standard test for the diagnosis of hypolactasia, since in addition to being a non-invasive test it is capable of distinguishing false positives and false negatives that appear in the tests performed using the older reference method: measurement of intestinal lactase in biopsy, taking as a comparison the normal limit used in clinical practice for this diagnostic test. These characteristics, along with the absence of adverse reactions in intolerant patients and the simplicity of carrying out the test, make the tests described in the present invention into an optimum functional diagnostic for the diagnosis of lactase intolerance.

Problems solved by technology

As a consequence of these effects, the digestion process is reduced and absorption of monosaccharides falls, giving rise to pain and abdominal cramps, flatulence, audible intestinal noise and diarrhoea.

In the newborn, congenital deficiency of the enzyme prevents proper utilisation of lactose resulting in severe disorders such as intense diarrhoea and dehydration, derived both from the reduction of energy input and the intestinal accumulation of non-hydrolysed disaccharide, which requires early detection and a change in diet to lactose-free milk.

Two classes of methodologies are used for the diagnosis of intestinal lactase deficiency or lactose intolerance, which have a series of disadvantages that in general imply poor reliability and serious discomfort for patients and also require specialised equipment.Direct determination of lactase activity in a sample of intestinal mucosa obtained by biopsy using endoscopy (Newcomer, A. D. et al., 1966; Gastroenterology 51, 481-88, Semenza, G. et al, 2001.

This is an invasive method, which only indicates enzyme activity in a specific part or area of the intestine, which is generally not the area of highest occurrence of the enzyme (middle jejunum), as it is very difficult to take biopsies in this area.

The main problems with these types of indirect test derive from the significant degree of accompanying digestive discomfort, as it is necessary to administer an oral overload of lactose in order to carry them out, this being particularly severe in infants.

Also, as these are indirect tests, they do not enable the evaluation of total enzyme activity in an individual but depend on endogenous production capacity of gases such as H2 and CO2 by the subject.

; so there is a high proportion of false positives and false negatives resulting in poor test reliability.

In summary, indirect methods, although non-invasive, suffer from three fundamental problems:i) serious accompanying discomfort to patients with lactase deficiency due to the high lactose doses that must be ingested in all cases;ii) need for special and unusual equipment and which is not always available in all health centres;iii) relative frequency of false positives and false negatives.

These drawbacks result in diagnoses of lactase deficiency being made much less frequently than the high level of incidence in the population would lead one to expect.

But these types of analogues have not been used in clinical practice as they imply the absorption into the bloodstream of a non-physiological compound, such as 3-O-methyl-D-glucose, and require gas chromatography or high pressure liquid chromatography systems for the determination.

However, one of the remaining problems in the state of the art is to determine the reference values beyond which a subject analysed could be considered to present lactose intolerance.

Moreover, this time are also excessive for processing a high number of samples.

Images